Creation and assessment of a predictive model for the risk of myocardial hypoperfusion following primary PCI in patients with ST-segment elevation myocardial infarction - Report - MDSpire

Creation and assessment of a predictive model for the risk of myocardial hypoperfusion following primary PCI in patients with ST-segment elevation myocardial infarction

  • By

  • Yan Zhao

  • Xiaoxia Fang

  • Huilin Li

  • Minglei Han

  • Fucheng Zhang

  • Mingming Qiao

  • April 21, 2026

  • 0 min

Share

Clinical Report: Predictive Model for Myocardial Hypoperfusion Post-PCI in STEMI

Overview

This study identifies key predictors of myocardial hypoperfusion following primary PCI in STEMI patients and develops a risk prediction model. The model demonstrates good predictive performance, suggesting its utility in clinical risk stratification.

Background

Myocardial hypoperfusion after primary PCI is a significant complication in patients with STEMI, impacting recovery and long-term outcomes. Understanding the determinants of this condition is crucial for optimizing treatment strategies and improving patient prognosis. Current approaches often lack comprehensive risk assessment tools that integrate multiple clinical factors.

Data Highlights

PredictorSignificance
Time from onset to PCIP < 0.05
Atorvastatin dose before PCIP < 0.05
Balloon deflation method during PCIP < 0.05
Red cell distribution width (RDW)P < 0.05
Monoamine oxidase (MAO) levelsP < 0.05

Key Findings

  • Five independent predictors of myocardial hypoperfusion were identified.
  • The nomogram showed AUC values of 0.855 in the training cohort and 0.838 in the validation cohort.
  • Calibration curves indicated good agreement between predicted and observed outcomes.
  • Decision curve analysis demonstrated the model's net benefit over treat-all and treat-none strategies.
  • Early identification of high-risk patients can optimize therapeutic strategies.

Clinical Implications

The identification of key predictors allows for early risk stratification in STEMI patients undergoing PCI. Implementing this predictive model in clinical practice may enhance decision-making and improve patient outcomes by facilitating timely interventions.

Conclusion

The developed risk prediction model for myocardial hypoperfusion post-PCI offers valuable insights for clinicians. Its favorable performance underscores the importance of early risk assessment in managing STEMI patients.

References

  1. Clinical Research in Cardiology, 2023 -- Tailored Diagnostic Approaches for Suspected Myocardial Infarction
  2. Clinical Research in Cardiology, 2025 -- Forecasting MRI-identified microvascular obstruction and its long-term consequences following acute myocardial infarction
  3. npj Digital Medicine, 2026 -- Assessment of Interpretable Artificial Intelligence for Diagnosing Coronary Artery Disease Using PET Biomarkers Across Multiple Centers
  4. Clinical Research in Cardiology, 2025 -- Assessing Risk in Heart Failure Through Invasive Hemodynamic Measurements
  5. Clinical Outcomes Associated With Various Microvascular Injury Patterns Identified by CMR After STEMI - PubMed
  6. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
  7. Prediction models for no-reflow phenomenon after PCI in acute coronary syndrome patients: A systematic review - ScienceDirect
  8. Clinical Outcomes Associated With Various Microvascular Injury Patterns Identified by CMR After STEMI
  9. 2025 ACC/AHA Guideline for Management of ACS
  10. Prediction models for no-reflow phenomenon after PCI in acute coronary syndrome patients: A systematic review - ScienceDirect

Original Source(s)

Related Content